Skip to main content
Year archive

ARGENT BIOPHARMA LIMITED — 2016 filings

All 103 regulatory filings released by ARGENT BIOPHARMA LIMITED (RGT) in 2016, sourced directly from the official regulator.

103 Filings
2016 Period
2016 filings (103)
Filing Released Lang
Appendix 3Y - Change of Director's Interest Notice 2 pages 200.1KB
Regulatory Filings
2016-12-27 English
Issue of Performance Rights - Appendix 3B 11 pages 383.1KB
Regulatory Filings
2016-12-22 English
MXC Operations Update 4 pages 734.3KB
Regulatory Filings
2016-12-21 English
New Panax Acquisition Agreement Signed, Settlement Imminent 4 pages 270.1KB
Regulatory Filings
2016-12-14 English
MXC Appoints ex Revlon Director to Fast Track Cosmetic Sales 3 pages 315.4KB
Regulatory Filings
2016-12-06 English
First Major European Sales and Revenue for MGC Derma Range 3 pages 288.6KB
Regulatory Filings
2016-12-01 English
Results of Annual General Meeting 1 page 128.5KB
Regulatory Filings
2016-11-28 English
Appendix 3B - Issue of Listed Options 12 pages 483.7KB
Regulatory Filings
2016-11-09 English
Cleansing Prospectus Closed 1 page 135.7KB
Regulatory Filings
2016-11-09 English
Cleansing Prospectus 32 pages 338.4KB
Regulatory Filings
2016-11-08 English
EU Registration Commenced for CBD Derma Product Sales 2 pages 187.2KB
Regulatory Filings
2016-11-06 English
September Quarter Activity and Cashflow Report 9 pages 321.6KB
Regulatory Filings
2016-10-26 English
Annual Report 2016 37 pages 1.9MB
Regulatory Filings
2016-10-25 English
Appendix 4G and Corporate Governance Statement 20 pages 410.5KB
Regulatory Filings
2016-10-25 English
Notice of Annual General Meeting/Proxy Form 23 pages 476.0KB
Regulatory Filings
2016-10-24 English
Appendix 3Y - Change of Director's Interest Notice x 3 7 pages 198.5KB
Regulatory Filings
2016-10-20 English
Issue of Performance Rights - Appendix 3B 12 pages 503.7KB
Regulatory Filings
2016-10-16 English
Listed Options now Quoted - ASX Code MXCOD 1 page 1
Regulatory Filings
2016-10-10 English
Issue of Listed Options from Capital Raisings - Appendix 3B 13 pages 527.1KB
Regulatory Filings
2016-10-05 English
Operations Update - Multiple Revenue Streams Imminent 3 pages 224.6KB
Regulatory Filings
2016-09-28 English
Results of General Meeting 1 page 138.0KB
Regulatory Filings
2016-09-26 English
New Med Cannabis White Paper Developed with Uni of Sydney 2 pages 212.7KB
Regulatory Filings
2016-09-20 English
Cleansing Prospectus Closed - No Shares Issued 1 pa
Regulatory Filings
2016-09-06 English
Cleansing Prospectus 31 pages 346.1KB
Regulatory Filings
2016-09-05 English
Strategic Agreement signed with Epilepsy Action Australia 2 pages 600.7KB
Regulatory Filings
2016-08-31 English
Q&A with Nativ Segev, MGC Pharmaceuticals Managing Director 1
Regulatory Filings
2016-08-29 English
Appendix 4E and Audited 2016 Financial Report 69 pages 1.7MB
Regulatory Filings
2016-08-28 English
Notice of General Meeting/Proxy Form 28 pages 632.9KB
Regulatory Filings
2016-08-25 English
Psoriasis and Acne Tests Advancing Ahead of Product Launch 2 pages 169.4KB
Regulatory Filings
2016-08-22 English
Appendix 3B - Issue of Consultant Shares 12 pages 374.2KB
Regulatory Filings
2016-08-11 English
Sale of Lingokoto and Bouroubourou Gold Exploration Assets 1
Regulatory Filings
2016-08-10 English
June Quarterly Activity and Cashflow Report 10 pages 1.3MB
Regulatory Filings
2016-07-27 English
Q&A with Dr Ross Walker, MGC Pharmaceuticals Director 1
Regulatory Filings
2016-07-19 English
Leading Epilepsy Expert Joins MXC Strategic Advisory Board 3 pages 207.4KB
Regulatory Filings
2016-07-12 English
First Revenues Received from Californian Cosmetics Deal 2 pages 169.9KB
Regulatory Filings
2016-06-26 English
Resignation of Director - Appendix 3Z 3 pages 275.8KB
Regulatory Filings
2016-06-23 English
Appendix 3B - Option Conversion 8 pages 255.4KB
Regulatory Filings
2016-06-22 English
MXC's First Crops Planted at European CBD Production Farm 3 pages 1.2MB
Regulatory Filings
2016-06-14 English
Completion of Priority Offer Share Allotment - Appendix 3B 13 pages 469.0KB
Regulatory Filings
2016-05-30 English
Health Canada Approves MGC Derma CBD Cosmetics 2 pages 167.0KB
Regulatory Filings
2016-05-29 English
Chairman's Update to Shareholders 2 pages 172.3KB
Regulatory Filings
2016-05-26 English
Appendix 3Y - Change of Director's Interest Notice 3 pages 195.5KB
Regulatory Filings
2016-05-26 English
FDA Approval Granted and First US Distribution Deal Signed 2 pages 173.5KB
Regulatory Filings
2016-05-24 English
Trading Halt 2 pages 359.5KB
Regulatory Filings
2016-05-22 English
Shareholder Priority Offer Closed Early - Oversubscribed 1
Regulatory Filings
2016-05-19 English
Form 605 - Notice of ceasing to be a substantial holder x 2 2 pages 150.1KB
Regulatory Filings
2016-05-15 English
Investor Presentation - May 2016 21 pages 1.7MB
Regulatory Filings
2016-05-15 English
Prospectus - Priority Offer 40 pages 400.7KB
Regulatory Filings
2016-05-15 English
Appendix 3B - Prospectus Priority Offer 12 pages 374.1KB
Regulatory Filings
2016-05-15 English
Completion and Allotment of Placement Shares 1 page
Regulatory Filings
2016-05-11 English
Priority Offer Timetable - Update 2 pages 166.6KB
Regulatory Filings
2016-05-11 English
European Commission Approves MGC Derma Cosmetics Products 2 pages 169.3KB
Regulatory Filings
2016-05-10 English
Appendix 3B - Option Conversion 8 pages 254.3KB
Regulatory Filings
2016-05-10 English
Appendix 3Y - Change of Director's Interest Notice 3 pages 196.0KB
Regulatory Filings
2016-05-10 English
Supplementary Prospectus 10 pages 212.5KB
Regulatory Filings
2016-05-10 English
Appendix 3B Updated - Prospectus 12 pages 386.5KB
Regulatory Filings
2016-05-10 English
ASX Approval of Panax Transaction and Capital Raising Update 2 pages 174.0KB
Regulatory Filings
2016-05-09 English
Reinstatement to Official Quotation 1 page 93.8KB
Regulatory Filings
2016-05-09 English
Senegal Gold Assets - Project Status Update 1 page
Regulatory Filings
2016-05-08 English
MXC to Raise $5.0m - Capital Raising Oversubscribed 3 pages 160.0KB
Regulatory Filings
2016-05-03 English
Prospectus 39 pages 461.7KB
Regulatory Filings
2016-05-03 English
Suspension from Official Quotation 1 page 257.4KB
Regulatory Filings
2016-05-03 English
March Quarterly Activity and Cashflow Report 8 pages 284.3KB
Regulatory Filings
2016-05-01 English
Trading Halt 2 pages 361.7KB
Regulatory Filings
2016-05-01 English
Response to ASX Aware Letter 5 pages 557.4KB
Regulatory Filings
2016-05-01 English
MXC to Acquire Licensed European Medical Cannabis Company 4 pages 1.1MB
Regulatory Filings
2016-04-26 English
Trading Halt 2 pages 364.0KB
Regulatory Filings
2016-04-21 English
Response to ASX Price Query 4 pages 468.9KB
Regulatory Filings
2016-04-17 English
Launch of Online Store - First Retail Sales of CBD Cosmetics 2 pages 171.0KB
Regulatory Filings
2016-04-12 English
MXC to Enter Australian Medicinal Cannabis Market 3 pages 189.3KB
Regulatory Filings
2016-04-03 English
MXC Publishes First Australian Med Cannabis White Paper 3 pages 173.1KB
Regulatory Filings
2016-03-28 English
MXC Secures First Cosmetics Sales Agreement 2 pages 130.1KB
Regulatory Filings
2016-03-23 English
Agreement with SipNose takes MXC into Global Epilepsy Market 3 pages 264.5KB
Regulatory Filings
2016-03-02 English
Half Yearly Report and Accounts 25 pages 599.7KB
Regulatory Filings
2016-02-28 English
Legalisation of Medical Cannabis Fast Tracks Aus Opportunity 2 pages 151.2KB
Regulatory Filings
2016-02-24 English
Managing Director's Update to Shareholders 2 pages 134.7KB
Regulatory Filings
2016-02-22 English
Investor Report by the Next Bio Tech 1 page 93.0KB
Regulatory Filings
2016-02-22 English
Reinstatement to Official Quotation (23/02/2016) 1
Regulatory Filings
2016-02-18 English
ASX Notice - Reinstatement to Official Quotation 2 pages 283.0KB
Regulatory Filings
2016-02-18 English
Pre-reinstatement disclosure 1 page 260.6KB
Regulatory Filings
2016-02-18 English
Distribution schedule & Top 20 Holders 1 page 107.7
Regulatory Filings
2016-02-18 English
Constitution 67 pages 473.1KB
Regulatory Filings
2016-02-18 English
Appendix 1A and Information Form and Checklist 18 pages 339.1KB
Regulatory Filings
2016-02-18 English
Confirmations 1 page 105.0KB
Regulatory Filings
2016-02-18 English
Terms and conditions of Performance Shares 2 pages 126.6KB
Regulatory Filings
2016-02-18 English
Corporate governance statement 10 pages 224.8KB
Regulatory Filings
2016-02-18 English
MGC Pharma (UK) Limited's account for 26/8/15 - 30/9/15 15 pages 1.2MB
Regulatory Filings
2016-02-18 English
Pro forma balance sheet as at 31 January 2016 1 pag
Regulatory Filings
2016-02-18 English
Securities trading policy 13 pages 277.5KB
Regulatory Filings
2016-02-18 English
Capital structure 1 page 93.9KB
Regulatory Filings
2016-02-18 English
Form 605 - Notice of ceasing to be a substantial holder x 2 3 pages 349.7KB
Regulatory Filings
2016-02-16 English
Form 603 - Notice of initial substantial holder x 2 4 pages 156.4KB
Regulatory Filings
2016-02-16 English
Completion of Acquisition - Appendix 3B 13 pages 406.4KB
Regulatory Filings
2016-02-15 English
Appendix 3Z - Final Director's Interest Notice 2 pages 166.2KB
Regulatory Filings
2016-02-15 English
Appendix 3X - Initial Director's Interest Notice x 3 6 pages 179.2KB
Regulatory Filings
2016-02-15 English
Managing Director's Update to Shareholders 2 pages 138.1KB
Regulatory Filings
2016-02-11 English
MGC Welcomes Medical Cannabis Legislation Change 3 pages 161.5KB
Regulatory Filings
2016-02-10 English
Issue of Supplementary Prospectus and Option Cancellation 1
Regulatory Filings
2016-02-10 English
Supplementary Prospectus 4 pages 143.6KB
Regulatory Filings
2016-02-10 English
December Quarterly Activity and Cashflow Report 9 pages 234.4KB
Regulatory Filings
2016-01-31 English
Conditional Reinstatement Letter Issued 1 page 81.7
Regulatory Filings
2016-01-26 English
App 3B Issue of July 15 Unlisted Options 12 pages 159.4KB
Regulatory Filings
2016-01-03 English
Prospectus Offers Closed 1 page 87.8KB
Regulatory Filings
2016-01-03 English